type 2 diabetes
Conditions
Interventions
A:Saxagliptin
Sponsors
Nanjing First Hospital, Nanjing Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Type 2 diabetes (HbA1c 7.5% to 11.0%, FPG <270mg/dL), equal or more than 18 years old, with the baseline treatment more than 8 weeks (insulin alone or combination therapy of insulin and metformin, the total daily dose of insulin is more than 20 and less than 150 units).
Exclusion criteria
Exclusion criteria: 1. Patiens accepted other drugs during the past 3 month; 2. A history of drug abuse alcohol dependence in the past 5 years; 3. using the intravenous hormone therapy; 4. Pregnancy, breast-feeding,or not using enough contraception(enough refers to the intrauterine device, oral contraceptives, prevent measures); 5. Poor adherence; 6. The probabl basic diseases which may obstruct this study,such as active malignancy, cardiomyopathy, mental disease; 7. There is infection during the past 4 weeks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| BMD; | — |
Secondary
| Measure | Time frame |
|---|---|
| OCN;ALP;Ca;P;PTH; | — |
Countries
China
Contacts
Public ContactXiaomei Liu
Nanjing First Hospital, Nanjing Medical University
Outcome results
None listed